Drug recall · July 15, 2015
Losartan potassium tablets USP recall
Why: Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Losartan potassium tablets USP, 50 mg, 90-count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India NDC 60505-3161-9
- Lots / codes
Lot #: KN1449, Exp 06/2015
- Quantity
- 23,076 bottles
- Company
- Apotex Inc., Toronto, N/A
- Distribution
- Nationwide, Hawaii and Puerto Rico
- Initiated
- May 29, 2015 · Voluntary: Firm initiated
- Classified
- July 7, 2015
- Reported
- July 15, 2015
- Ended
- March 3, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Losartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.